Jay Giri, MD
Interventional Cardiology · Philadelphia, PANPI 1881892669
Payments from drug & device makers
Across 998 payments — averaging $1034.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$617K
- Boston Scientific$316K
- Abbott$31K
- Edwards Lifesciences$17K
- Stryker$17K
- AstraZeneca$8K
- plus $27K from 20 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 642 | $617,035 |
| Boston Scientific | 84 | $316,025 |
| Abbott | 31 | $30,832 |
| Edwards Lifesciences | 55 | $16,677 |
| Stryker | 4 | $16,650 |
| AstraZeneca | 15 | $8,224 |
| Abiomed | 21 | $6,239 |
| Endovascular Engineering Inc. | 7 | $5,446 |
| Medtronic(2 entities) | 95 | $5,240 |
| Novartis | 3 | $4,015 |
| Cordis US CORP. | 3 | $2,960 |
| Angiodynamics, Inc. | 1 | $1,250 |
| Shockwave Medical, Inc | 11 | $471 |
| Johnson & Johnson | 4 | $323 |
| Penumbra, Inc. | 5 | $298 |
| Terumo Medical Corporation | 1 | $130 |
| Philips North America LLC | 2 | $128 |
| Cook Medical LLC | 1 | $124 |
| Siemens Medical Solutions USA, Inc. | 1 | $120 |
| Cagent Vascular Inc | 2 | $93 |
| Cathworks, Inc. | 3 | $67 |
| Teleflex LLC | 2 | $38 |
| W. L. Gore & Associates, Inc. | 2 | $37 |
| Janssen Scientific Affairs, LLC | 1 | $25 |
| BTG International Inc. | 1 | $20 |
| Heartflow, Inc. | 1 | $18 |
How this compares
$1,032,486 in reported general payments places this provider in the 95th percentile of 281 interventional cardiology providers in Pennsylvania.
See all interventional cardiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Philadelphia
- Howard HerrmannPhiladelphia$2.2M
- Sameer KhandharPhiladelphia$831K
- Jon GeorgePhiladelphia$728K
- Taisei KobayashiPhiladelphia$473K
- Sanjog KalraPhiladelphia$462K
- Ashwin NathanPhiladelphia$328K
- Gene ChangPhiladelphia$217K
- Sahil BankaPhiladelphia$148K
- Paul FiorilliPhiladelphia$134K
- Oleg VishnevskyPhiladelphia$121K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.